best mid cap stocks on march 16, 2026

BioCryst Pharmaceuticals (BCRX) had the highest return on March 16 by a mid-cap US stock, returning 13.1%.

ASSETDATE% RETURN
BioCryst Pharmaceuticals (BCRX)
3/16/2026
13.14%
Veradermics (MANE)
3/16/2026
8.23%
Spyre Therapeutics (SYRE)
3/16/2026
8.2%
Forgent Power Solutions (FPS)
3/16/2026
8%
Strive (ASST)
3/16/2026
7.63%
Solaris Energy Infrastructure (SEI)
3/16/2026
6.09%
Molson Coors Beverage (TAP.A)
3/16/2026
6.02%
Navios Maritime Partners LP Unit (NMM)
3/16/2026
5.96%
CAVA (CAVA)
3/16/2026
5.91%
Terawulf (WULF)
3/16/2026
5.87%
nLIGHT (LASR)
3/16/2026
5.83%
Astronics (ATRO)
3/16/2026
5.47%
United States Lime & Minerals (USLM)
3/16/2026
5.25%
Materion (MTRN)
3/16/2026
5.17%
Impinj (PI)
3/16/2026
5.04%
Dutch Bros (BROS)
3/16/2026
5.04%
Accelerant (ARX)
3/16/2026
4.9%
Acuren (TIC)
3/16/2026
4.83%
Pharvaris (PHVS)
3/16/2026
4.75%
Vita Coco (COCO)
3/16/2026
4.52%
ADMA Biologics (ADMA)
3/16/2026
4.49%
Sphere Entertainment (SPHR)
3/16/2026
4.48%
Caris Life Sciences, Inc Common Stock (CAI)
3/16/2026
4.38%
Bullish (BLSH)
3/16/2026
4.26%
Custom Truck One Source (CTOS)
3/16/2026
4.23%
Mid-cap stocks are treated as having a market cap between $2B and $10B.